Clinical Trial Update: Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 trial update for fluoxetine and bupropion in patients with depression and alcoholism; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism
• Major Depressive Disorder

Drugs mentioned

• Fluoxetine and bupropion

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Depression, Alcoholism | Phase 4 | Status: TERMINATED | Results posted: 2021-07-16